Envestnet, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Goodwill and Intangible Assets, Net

Three Months Ended

Amortization expense

Goodwill and Intangible Assets, Net

3 Months Ended

Mar. 31, 2018

Goodwill and Intangible Assets, Net

Goodwill and Intangible Assets, Net

9.Goodwill & Intangible Assets, Net

Changes in the carrying amount of goodwill were as follows:


	Envestnet		Envestnet \| Yodlee		Total
Balance at December 31, 2017	$	163,751	$	269,204	$	432,955
FolioDynamix acquisition		97,248		—		97,248
Foreign currency		—		(176)		(176)
Balance at March 31, 2018	$	260,999	$	269,028	$	530,027

Intangible assets, net consist of the following:


					March 31, 2018						December 31, 2017
					Gross				Net		Gross				Net
	Estimated				Carrying		Accumulated		Carrying		Carrying		Accumulated		Carrying
	Useful Life				Amount		Amortization		Amount		Amount		Amortization		Amount
Customer lists	7	-	15	years	$	354,350	$	(87,244)	$	267,106	$	259,350	$	(78,482)	$	180,868
Proprietary technologies	4	-	8	years		76,043		(34,984)		41,059		57,377		(31,067)		26,310
Trade names	1	-	7	years		29,540		(10,870)		18,670		24,840		(9,701)		15,139
Backlog			4	years		11,000		(10,673)		327		11,000		(10,586)		414
Total intangible assets					$	470,933	$	(143,771)	$	327,162	$	352,567	$	(129,836)	$	222,731

Amortization expense was as follows:

Future amortization expense of the intangible assets as of March 31, 2018, is expected to be as follows:


Years ending December 31:
Remainder of 2018	$	39,500
2019		47,727
2020		43,591
2021		34,811
2022		32,223
Thereafter		129,310
	$	327,162

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details